51![Vismodegib Pediatric Development Vismodegib Pediatric Development](https://www.pdfsearch.io/img/11246704340e13c6ae1a07dcaf438e02.jpg) | Add to Reading ListSource URL: www.fda.govLanguage: English |
---|
52![CITY: HIGHLANDS RANCH, CO DIV/GROUP: ENV/IM DB: BGRIFFITH LD: G FRANCE PATH: W:\GISPRJ\GISPROJECTS\_ENV\FHR_AK\NORTHPOLEREFINERY\GW_MONITORING\2013_Q3\MXD\FIG 3-1 PRIVATEWELL_SULFOLANE.MXD DATE: [removed]TIME: 4:50:20 CITY: HIGHLANDS RANCH, CO DIV/GROUP: ENV/IM DB: BGRIFFITH LD: G FRANCE PATH: W:\GISPRJ\GISPROJECTS\_ENV\FHR_AK\NORTHPOLEREFINERY\GW_MONITORING\2013_Q3\MXD\FIG 3-1 PRIVATEWELL_SULFOLANE.MXD DATE: [removed]TIME: 4:50:20](https://www.pdfsearch.io/img/b124b540f30b59a0b5852a433b3b01ac.jpg) | Add to Reading ListSource URL: dec.alaska.govLanguage: English - Date: 2014-02-07 18:28:24
|
---|
53![Microsoft Office Outlook - Memo Style Microsoft Office Outlook - Memo Style](https://www.pdfsearch.io/img/5a76505b9470fb735007822659f021a1.jpg) | Add to Reading ListSource URL: dec.alaska.govLanguage: English - Date: 2013-05-20 13:46:25
|
---|
54![Food and Drug Administration Advisory Committee Member Acknowledgment of Financial Interests Name of Temporary Advisory Committee Member: Joanne Mortimer, M.D. Committee: Oncologic Drugs Advisory Committee Meeting Date: Food and Drug Administration Advisory Committee Member Acknowledgment of Financial Interests Name of Temporary Advisory Committee Member: Joanne Mortimer, M.D. Committee: Oncologic Drugs Advisory Committee Meeting Date:](https://www.pdfsearch.io/img/d1e1661fd3bc9930405666fb9400181e.jpg) | Add to Reading ListSource URL: www.fda.govLanguage: English |
---|
55![DEPARTMENT OF HEALTH & HUMAN SERVICES Public Health Service Food and Drug Administration Silver Spring MD 20993 DEPARTMENT OF HEALTH & HUMAN SERVICES Public Health Service Food and Drug Administration Silver Spring MD 20993](https://www.pdfsearch.io/img/c18ee39084061e7f2b77ae7007bc9442.jpg) | Add to Reading ListSource URL: www.fda.govLanguage: English |
---|
56![DHSS Community Concerns Sulfolane Health Fact Sheet[removed] DHSS Community Concerns Sulfolane Health Fact Sheet[removed]](https://www.pdfsearch.io/img/715e60648e41750cd4b48760b614650a.jpg) | Add to Reading ListSource URL: dec.alaska.govLanguage: English - Date: 2014-05-06 16:30:46
|
---|
57![Microsoft Office Outlook - Memo Style Microsoft Office Outlook - Memo Style](https://www.pdfsearch.io/img/0d900eec7c9431ad15726c616f6101d8.jpg) | Add to Reading ListSource URL: dec.alaska.govLanguage: English - Date: 2013-05-20 13:46:01
|
---|
58![Microsoft Office Outlook - Memo Style Microsoft Office Outlook - Memo Style](https://www.pdfsearch.io/img/6b3b00eba845e24cbe6624653417b4de.jpg) | Add to Reading ListSource URL: dec.alaska.govLanguage: English - Date: 2013-05-20 13:46:29
|
---|
59![Microsoft Office Outlook - Memo Style Microsoft Office Outlook - Memo Style](https://www.pdfsearch.io/img/2f9abc2f30f859d30de92e8d15a1a411.jpg) | Add to Reading ListSource URL: dec.alaska.govLanguage: English - Date: 2013-05-20 13:47:06
|
---|
60![HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use AXERT® safely and effectively. See full prescribing information for AXERT®. AXERT® (almotriptan malate) Tablets f HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use AXERT® safely and effectively. See full prescribing information for AXERT®. AXERT® (almotriptan malate) Tablets f](https://www.pdfsearch.io/img/1d672354b00709ae92f2668637e4446b.jpg) | Add to Reading ListSource URL: www.axert.comLanguage: English - Date: 2014-09-14 10:57:17
|
---|